Tolerability and efficacy of bimatoprost 0.01 % in patients with open-angle glaucoma or ocular hypertension evaluated in the Taiwanese clinical setting: the Asia Pacific Patterns from Early Access of Lumigan 0.01 % (APPEAL Taiwan) study

Lignende værker

• An observational study of bimatoprost 0.01% in patients on prior intraocular pressure-lowering therapy: the Canadian Lumigan(®) RC Early Analysis Review (CLEAR) trial
  af: Crichton, Andrew C, et al.
  Udgivet: (2014)
• Impact of topical bimatoprost 0.01% and bimatoprost 0.03% on conjunctival irritation in rabbits
  af: Ogundele, Abayomi B, et al.
  Udgivet: (2010)
• Aqueous humor penetration of topical bimatoprost 0.01% and bimatoprost 0.03% in rabbits
  af: Ogundele, Abayomi B, et al.
  Udgivet: (2010)
• Aqueous humor penetration of topical bimatoprost 0.01% and bimatoprost 0.03% in rabbits: response to authors
  af: Chang-Lin, Joan-En, et al.
  Udgivet: (2011)
• Bimatoprost 0.01% in treatment-naïve patients with open-angle glaucoma or ocular hypertension: an observational study in the Korean clinical setting
  af: Park, Ki Ho, et al.
  Udgivet: (2014)